Monitoring Radiotherapeutic Response in Prostate Cancer Patients Using High Throughput FTIR Spectroscopy of Liquid Biopsies
Radiation therapy (RT) is used to treat approximately 50% of all cancer patients. However, RT causes a wide range of adverse late effects that can affect a patient’s quality of life. There are currently no predictive assays in clinical use to identify patients at risk of normal tissue radi...
Main Authors: | Dinesh K.R. Medipally, Thi Nguyet Que Nguyen, Jane Bryant, Valérie Untereiner, Ganesh D. Sockalingum, Daniel Cullen, Emma Noone, Shirley Bradshaw, Marie Finn, Mary Dunne, Aoife M. Shannon, John Armstrong, Fiona M. Lyng, Aidan D. Meade |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/7/925 |
Similar Items
-
Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis
by: Dinesh K. R. Medipally, et al.
Published: (2020-07-01) -
Analysis of Hepatic Fibrosis Characteristics in Cirrhotic Patients with and without Hepatocellular Carcinoma by FTIR Spectral Imaging
by: Johanna Moreau, et al.
Published: (2020-09-01) -
Regulatory T cells in radiotherapeutic responses
by: Dörthe eSchaue, et al.
Published: (2012-08-01) -
Integrin Targeted Delivery of Radiotherapeutics
by: Zhaofei Liu, Fan Wang, Xiaoyuan Chen
Published: (2011-01-01) -
Targeted Radiotherapeutics from 'Bench-to-Bedside'
by: Cristina Müller, et al.
Published: (2020-12-01)